l-carnitine supplementation decreased DBP (1.162 mmHg, 95% CI: 2.020, 0.303, p = 0.008) without changing SBP levels (0.085 mmHg, 95% CI: 1.455, 1.285, p = 0.903)
However, current evidence is insufficient to recommend LC as a broadly ergogenic supplement for performance enhancement (Oliveira and Sousa 2019)
Eventually, regulatory bodies and healthcare stakeholders must work together to guarantee the safety and effectiveness of liposomal formulations, while also establishing a structure for their authorization and extensive utilisation
These kinases phosphorylate the membrane transporters (DAT, NET, SERT), leading to two outcomes: the transporters are either internalized into the cell (ceasing all reuptake function) or they undergo a conformational shift that causes them to operate in reverse